NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.
The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.
At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.
NLS plans to use the net proceeds for general corporate purposes.
The shares of NLS Pharmaceutics were up nearly 2% in recent trading.
Price: 2.74, Change: +0.04, Percent Change: +1.67
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。